Murray Korc

Q: What Schools Are Affiliated With Murray Korc

Murray Korc is affiliated with the following schools: Indiana University Bloomington, Indiana University, University of California, Irvine, California Institute of Technology, University of Arizona, Stanford University, University of Copenhagen, University of Bern, Technical University of Munich, New York University, Arizona Board of Regents

Murray Korc's AcademicInfluence.com Rankings

Murray Korc

Biology

#6211

World Rank

#8879

Historical Rank

#2023

USA Rank

Molecular Biology

#626

World Rank

#641

Historical Rank

#163

USA Rank

Neuroscience

#741

World Rank

#773

Historical Rank

#187

USA Rank

biology Degrees

Download Badge

Biology

Murray Korc's Degrees

PhD Molecular Biology Stanford University

Why Is Murray Korc Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Murray Korc's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. (1988) (835)
Pancreatic cancer (1988) (797)
Cancer-associated cachexia (2018) (723)
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. (1993) (565)
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. (1992) (528)
In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. (2000) (443)
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. (1993) (438)
Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. (1978) (417)
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. (2010) (380)
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. (1998) (349)
Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. (1993) (339)
Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. (1995) (338)
The role of fibroblast growth factors in tumor growth. (2009) (301)
Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. (1997) (275)
Pancreatic islet-acinar cell interaction: amylase messenger RNA levels ar determined by insulin. (1981) (266)
Pancreatic cancer-associated stroma production. (2007) (264)
Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. (2001) (264)
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders (2001) (262)
Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer (2017) (261)
Role of growth factors in pancreatic cancer. (1998) (254)
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer (1999) (253)
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer (2017) (245)
Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia. (2009) (244)
Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. (1987) (237)
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. (2016) (236)
Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. (1995) (234)
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. (2009) (231)
Overexpression of HER2/neu oncogene in human pancreatic carcinoma. (1993) (223)
Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. (1999) (223)
Concomitant over‐expression of vascular endothelial growth factor and its receptors in pancreatic cancer (2000) (219)
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. (2008) (215)
Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. (1986) (214)
Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. (1997) (213)
Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. (2009) (204)
Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. (1994) (193)
Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. (1990) (191)
p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. (1993) (190)
Uncovering Growth-Suppressive MicroRNAs in Lung Cancer (2009) (189)
Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. (1999) (186)
KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. (1996) (183)
Pathways for aberrant angiogenesis in pancreatic cancer (2003) (182)
Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. (1993) (174)
Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes (2015) (172)
Membrane-Associated Heparan Sulfate Proteoglycans Are Involved in the Recognition of Cellular Targets by NKp30 and NKp461 (2004) (169)
Induction and expression of amphiregulin in human pancreatic cancer. (1994) (166)
Pancreatic cancer stroma: friend or foe? (2014) (166)
Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. (1998) (158)
Connective tissue growth factor–specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer (2006) (156)
Syndecan‐1 expression is up‐regulated in pancreatic but not in other gastrointestinal cancers (2000) (156)
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells. (2008) (155)
Nerve growth factor and its high-affinity receptor in chronic pancreatitis. (1999) (155)
Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. (1999) (155)
Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. (1994) (154)
Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. (1993) (146)
Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. (1995) (144)
MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma (2011) (140)
Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. (1999) (140)
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer (2003) (139)
A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. (1994) (139)
Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. (1998) (139)
Detection and localization of MIP‐3α/LARC/exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer (1999) (138)
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. (1999) (137)
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia (2007) (137)
Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer. (2012) (133)
Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells (2000) (133)
Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. (2007) (129)
Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. (1994) (129)
Pancreatic cancer: Stroma and its current and emerging targeted therapies. (2017) (126)
Induction of platelet‐derived growth factor A and B chains and over‐expression of their receptors in human pancreatic cancer (1995) (126)
Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines (2004) (123)
Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. (1999) (122)
Pancreatitis-Diabetes-Pancreatic Cancer: Summary of an NIDDK-NCI Workshop (2013) (122)
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. (1999) (120)
Growth factor–induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells (2005) (119)
Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. (1999) (117)
Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. (2003) (117)
Highly Specific Plasmonic Biosensors for Ultrasensitive MicroRNA Detection in Plasma from Pancreatic Cancer Patients (2014) (116)
Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition (1996) (115)
Critical role of NF-κB in pancreatic cancer (2014) (113)
Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions (1997) (112)
Neuropilin-1 interacts with integrin β1 and modulates pancreatic cancer cell growth, survival and invasion (2007) (112)
Role of Fibroblast Growth Factors and Their Receptors in Pancreatic Cancer and Chronic Pancreatitis (1998) (111)
Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells (2002) (105)
Neurokinin-1 Receptor Expression and Its Potential Effects on Tumor Growth in Human Pancreatic Cancer (2003) (105)
Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors (2010) (103)
A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile (2014) (103)
Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. (1998) (102)
Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis. (2002) (102)
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Induces Growth Inhibition and Enhances Gemcitabine-Induced Cell Death in Pancreatic Cancer (2007) (102)
bax, but notbcl-2, influences the prognosis of human pancreatic cancer (1998) (102)
Loss of beta-catenin expression in metastatic gastric cancer. (2003) (101)
The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer. (1998) (101)
Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. (2003) (99)
Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. (1998) (98)
Increased Cyclin D1 in Human Pancreatic Cancer Is Associated with Decreased Postoperative Survival (1998) (97)
Cripto, a member of the epidermal growth factor family, is over‐expressed in human pancreatic cancer and chronic pancreatitis (1994) (96)
Galectin-1 and Galectin-3 in Chronic Pancreatitis (2000) (96)
Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells (2004) (96)
Overexpression of activin A in stage IV colorectal cancer (2001) (95)
Pancreatic cancer cell‐derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo (2001) (95)
Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis (2011) (94)
Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma. (1994) (93)
Epiregulin is Up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. (2000) (92)
microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions (2013) (91)
Cdk4/6 Inhibition Induces Epithelial–Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells (2012) (91)
Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. (2001) (91)
Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer. (1999) (91)
KAI1, A new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma (1998) (90)
Overexpression of Lymphangiogenic Growth Factor VEGF-C in Human Pancreatic Cancer (2001) (88)
Insulin action in pancreatic acini from streptozotocin-treated rats. I. Stimulation of protein synthesis. (1981) (88)
Molecular Aspects of Pancreatic Cancer and Future Perspectives (1999) (88)
Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors (2004) (88)
Effects of enterally fed epidermal growth factor on the small and large intestine of the suckling rat (1987) (88)
Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. (1994) (85)
Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma (2015) (83)
Soluble Type II Transforming Growth Factor-β (TGF-β) Receptor Inhibits TGF-β Signaling in COLO-357 Pancreatic Cancer Cells in Vitro and Attenuates Tumor Formation (2001) (83)
Adhesion molecules in human pancreatic cancer * (2002) (83)
Synthesis and Expression of Transforming Growth Factor β-1, β-2, and β-3 in the Endocrine and Exocrine Pancreas (1993) (83)
Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. (1999) (81)
Increased expression of insulin receptor substrate-1 in human pancreatic cancer. (1996) (80)
Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. (1998) (80)
Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer (2011) (79)
Concomitant Analysis of the Epidermal Growth Factor Receptor Family in Esophageal Cancer: Overexpression of Epidermal Growth Factor Receptor mRNA but Not of c-erbB-2 and c-erbB-3 (1999) (78)
Advances, challenges, and limitations in serum-proteome-based cancer diagnosis. (2006) (78)
Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma (2004) (78)
Up-regulation of Transforming Growth Factor (TGF)-β Receptors by TGF-β1 in COLO-357 Cells* (1998) (78)
Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. (2017) (77)
Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formation. (2004) (77)
Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases (1998) (76)
Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma (1999) (76)
Biomimetic and enzyme-responsive dynamic hydrogels for studying cell-matrix interactions in pancreatic ductal adenocarcinoma. (2018) (75)
Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions. (2011) (74)
Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo. (1998) (74)
Suppression of transforming growth factor β signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations (2006) (74)
Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice Expressing Oncogenic Kras in the Nestin Cell Lineage (2011) (73)
Co‐expression of heparin‐binding EGF‐like growth factor and related peptides in human gastric carcinoma (1996) (73)
Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. (2004) (73)
Tobacco and alcohol as risk factors for pancreatic cancer. (2017) (73)
Obesity Is Mediated by Differential Aryl Hydrocarbon Receptor Signaling in Mice Fed a Western Diet (2012) (72)
DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance (2011) (72)
Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. (1999) (72)
Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. (1997) (72)
Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor‐targeted therapy (1997) (71)
A KrasG12D-Driven Genetic Mouse Model of Pancreatic Cancer Requires Glypican-1 for Efficient Proliferation and Angiogenesis (2011) (71)
Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. (1993) (70)
Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. (2000) (69)
Transfection of the type I TGF‐β receptor restores TGF‐β responsiveness in pancreatic cancer (1998) (69)
ErbB‐4 mRNA expression is decreased in non‐metastatic pancreatic cancer (1999) (69)
Concomitant over‐expression of activin/inhibin β subunits and their receptors in human pancreatic cancer (1998) (69)
Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. (2007) (69)
Insulin receptors in isolated mouse pancreatic acini. (1978) (68)
Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-alpha. (1989) (67)
Epithelial Splicing Regulatory Protein 1 is a Favorable Prognostic Factor in Pancreatic Cancer that Attenuates Pancreatic Metastases (2013) (67)
FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth (2006) (66)
Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. (1999) (66)
p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness. (1994) (65)
Bcl‐xl antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine (2001) (65)
Increased expression of keratinocyte growth factor in human pancreatic cancer. (1995) (65)
Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. (1987) (65)
Transforming Growth Factor-βs and Their Signaling Receptors Are Coexpressed in Crohn's Disease (1999) (64)
Erratum: microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions (2014) (64)
Altered Expression and Localization of the Tight Junction Protein ZO-1 in Primary and Metastatic Pancreatic Cancer (2001) (63)
Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum (1996) (62)
Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. (1999) (62)
14-3-3σ Modulates Pancreatic Cancer Cell Survival and Invasiveness (2008) (61)
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models. (2016) (60)
Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer. (1999) (60)
Differential localization of transforming growth factor‐β isoforms in human gastric mucosa and overexpression in gastric carcinoma (1997) (60)
Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation. (2012) (60)
Induction and expression of βig-h3 in pancreatic cancer cells (2002) (59)
Manganese action on pancreatic protein synthesis in normal and diabetic rats. (1983) (59)
Thiol-ene hydrogels as desmoplasia-mimetic matrices for modeling pancreatic cancer cell growth, invasion, and drug resistance. (2014) (59)
Pathophysiological role of microRNA-29 in pancreatic cancer stroma (2015) (58)
A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells (2011) (58)
Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K‐Ras transgenic mouse model of pancreatic cancer (2012) (57)
Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Apoptosis in Pancreatic Cancer (2004) (57)
Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. (1997) (56)
Fas and Fas-ligand expression in human pancreatic cancer. (2000) (56)
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models (2016) (56)
AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia (2012) (55)
Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line. (1990) (55)
Inherent and benzo[a]pyrene-induced differential aryl hydrocarbon receptor signaling greatly affects life span, atherosclerosis, cardiac gene expression, and body and heart growth in mice. (2012) (55)
Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. (2009) (55)
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine (2014) (55)
Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells. (2004) (54)
Insulin action in pancreatic acini from streptozotocin-treated rats. II. Binding of 125I-insulin to receptors. (1981) (54)
Insulin-Like Growth Factor I Improves Cardiovascular Function and Suppresses Apoptosis of Cardiomyocytes in Dilated Cardiomyopathy1. (1999) (54)
Enzyme-mediated stiffening hydrogels for probing activation of pancreatic stellate cells. (2017) (52)
Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor. (2002) (52)
Binding of epidermal growth factor in rat pancreatic acini. (1983) (50)
Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study (2017) (49)
Expression of the Multidrug-Resistance 1 (MDR1) Gene and Prognosis in Human Pancreatic Cancer (2000) (49)
bax , but not bcl-2 , inﬂuences the prognosis of human pancreatic cancer (1998) (49)
Differential Regulation of Fibroblast Growth Factor (FGF) Receptor-1 mRNA and Protein by Two Molecular Forms of Basic FGF (1996) (48)
Activated K‐Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype (2013) (48)
Binding and Biological Effects of Tumor Necrosis Factor and Gamma Interferon in Human Pancreatic Carcinoma Cells (1990) (48)
Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential (2016) (48)
Recycling of epidermal growth factor in a human pancreatic carcinoma cell line. (1985) (48)
Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells (2018) (47)
Altered expression of transforming growth factor-βs in chronic renal rejection (1996) (47)
IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells. (2002) (47)
A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini. (1987) (47)
Induction and expression of betaig-h3 in pancreatic cancer cells. (2002) (47)
Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. (2000) (47)
Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. (2014) (46)
Stimulation of the glucose transport system in isolated mouse pancreatic acini by cholecystokinin and analogues. (1979) (45)
Activated K-ras and INK4a/Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NF-κB Signaling Pathways (2011) (45)
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. (2012) (44)
Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation. (2001) (44)
Presence of Two Signaling TGF-β Receptors in Human Pancreatic Cancer Correlates with Advanced Tumor Stage (1997) (44)
Smad7 Abrogates Transforming Growth Factor-β1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein* (2005) (44)
Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway. (2009) (44)
Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma. (2006) (44)
A Subgroup of Patients with Chronic Pancreatitis Overexpress the c‐erb B‐2 Protooncogene (1994) (43)
Diabetes Mellitus in the Era of Proteomics (2003) (43)
Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS1 Kinase Inhibitor NMS-P715 (2013) (42)
Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma. (2016) (42)
Involvement of microRNAs in lung cancer biology and therapy. (2011) (42)
Modular and Adaptable Tumor Niche Prepared from Visible Light Initiated Thiol-Norbornene Photopolymerization. (2016) (42)
Signaling pathways in pancreatic cancer. (2011) (41)
Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line. (1991) (41)
Altered Expression of Insulin‐like Growth Factor II Receptor in Human Pancreatic Cancer (1997) (40)
Betacellulin, a member of the epidermal growth-factor family, is overexpressed in human pancreatic-cancer. (1995) (39)
Amphiregulin is a potent mitogen in human pancreatic-cancer cells - correlation with patient survival. (1995) (38)
Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4. (1999) (38)
TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis (2015) (38)
KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers. (1998) (38)
Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells. (1998) (37)
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy (2021) (37)
Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage. (2001) (37)
Restoration of Smad4 in BxPC3 Pancreatic Cancer Cells Attenuates Proliferation without Altering Angiogenesis (2005) (36)
The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. (2018) (36)
Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of γ-interferon receptors (1993) (36)
Connective Tissue Growth Factor is Involved in Pancreatic Repair and Tissue Remodeling in Human and Rat Acute Necrotizing Pancreatitis (2002) (36)
Targeting angiogenesis in pancreatic cancer: rationale and pitfalls (2008) (36)
Receptors for cholecystokinin and insulin in isolated pancreatic acini: hormonal control of secretion and metabolism. (1981) (35)
Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases (2008) (35)
Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis. (1997) (35)
Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice. (2014) (35)
Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes (2015) (35)
Kinase signaling pathways as targets for intervention in pancreatic cancer (2010) (35)
Cytosolic calcium regulates epidermal growth factor endocytosis in rat pancreas and cultured fibroblasts. (1983) (34)
Processing of epidermal growth factor by suckling and adult rat intestinal cells. (1986) (33)
Regulation of Transforming Growth Factor‐α mRNA Expression in T3M4 Human Pancreatic Carcinoma Cells (1991) (33)
Expression and differential signaling of heregulins in pancreatic cancer cells (2007) (33)
Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer. (1998) (33)
Regulation of protein synthesis in normal and diabetic rat pancreas by cholecystokinin. (1981) (32)
Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip. (2016) (32)
Microarray analysis of cytoplasmic versus whole cell RNA reveals a considerable number of missed and false positive mRNAs. (2009) (32)
Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model. (2005) (32)
Defined Localization of Nestin-expressing Cells in l-arginine-induced Acute Pancreatitis (2006) (32)
Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth. (2007) (31)
Overexpression of Platelet-Derived Growth Factor (PDGF) B Chain and Type β PDGF Receptor in Human Chronic Pancreatitis (1998) (31)
Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers (2017) (31)
Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors (2002) (31)
Transforming growth factor betas and their receptors in human liver cirrhosis (1998) (30)
Overexpression of Smad2 and Colocalization with TGF-β1 in Human Pancreatic Cancer (1999) (30)
Expression of the High Molecular Weight Fibroblast Growth Factor-2 Isoform of 210 Amino Acids Is Associated with Modulation of Protein Kinases C δ and ε and ERK Activation* (2001) (30)
Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis (1998) (29)
Growth factors and pancreatic cancer (1991) (29)
Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model. (2016) (29)
Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma. (2006) (29)
Regulation of pancreatic protein synthesis by cholecystokinin and calcium. (1982) (28)
Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. (1993) (28)
Processing and transfer of epidermal growth factor in developing rat jejunum and ileum (1990) (28)
Alteration of fibroblast growth factor and receptor expression after acute pancreatitis in humans. (1999) (28)
Islet growth factors: curing diabetes and preventing chronic pancreatitis? (1993) (27)
A method for conducting highly sensitive microRNA in situ hybridization and immunohistochemical analysis in pancreatic cancer. (2013) (27)
Activator Protein-1 Has an Essential Role in Pancreatic Cancer Cells and Is Regulated by a Novel Akt-Mediated Mechanism (2007) (27)
Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer. (2002) (27)
Epidermal growth factor inhibits the proliferation of a human endometrial carcinoma cell line. (1986) (26)
Driver mutations (2010) (26)
Basic fibroblast growth factor is a calcium-mobilizing secretagogue in rat pancreatic acini. (1991) (25)
Coexpression of FAS and FAS-Ligand in Chronic Pancreatitis: Correlation with Apoptosis (2000) (25)
Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. (2018) (25)
Pancreatic Cancer–Associated Diabetes Is an “Exosomopathy” (2015) (24)
Cloning of a variant epidermal growth factor receptor. (1993) (24)
Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells (2001) (24)
COMP is Selectively Up-regulated in Degenerating Acinar Cells in Chronic Pancreatitis and in Chronic-Pancreatitis-like Lesions in Pancreatic Cancer (2003) (23)
Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer (2012) (23)
Alterations of pancreatic digestive enzyme content in the manganese-deficient rat. (1987) (23)
TGF‐β‐1 up‐regulates cyclin D1 expression in colo‐357 cells, whereas suppression of cyclin d1 levels is associated with down‐regulation of the type I TGF‐β receptor (1999) (23)
Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis (2017) (23)
Molecular imaging in pancreatic cancer--a roadmap for therapeutic decisions. (2013) (22)
Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. (2016) (22)
Ligand induced upregulation of the type II transforming growth factor (TGF-β) receptor enhances TGF-β responsiveness in COLO-357 cells (1999) (21)
Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells (1999) (21)
Identification of Malignancy Factors by Analyzing Cystic Tumors of the Pancreas (2008) (20)
Epidermal growth factor inhibits rat pancreatic cell proliferation, causes acinar cell hypertrophy, and prevents caerulein-induced desensitization of amylase release. (1989) (20)
Smad4: gatekeeper gene in head and neck squamous cell carcinoma. (2009) (20)
Trials and tribulations of pancreatic cancer immunotherapy. (2021) (20)
Dietary modulation of epidermal growth factor action in cultured pancreatic acinar cells of the rat. (1986) (20)
Adenovirus-Mediated Transfer of a Truncated Fibroblast Growth Factor (FGF) Type I Receptor Blocks FGF-2 Signaling in Multiple Pancreatic Cancer Cell Lines (2004) (20)
Metastatic Pancreatic Adenocarcinoma After Total Pancreatectomy Islet Autotransplantation for Chronic Pancreatitis (2016) (19)
Upregulation of interferon-gamma binding by tumor necrosis factor and lymphotoxin: disparate potencies of the cytokines and modulation of their effects by phorbol ester. (1991) (19)
Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells. (1985) (18)
Effects of dietary manganese deficiency on rat pancreatic amylase mRNA levels. (1990) (18)
Increased Cyclin D1 Expression in Chronic Pancreatitis (1998) (18)
Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters. (1996) (17)
Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation. (2001) (17)
Epidermal growth factor binding is altered in pancreatic acini from diabetic rats. (1984) (17)
Intra-Tumoral Delivery of shRNA Targeting Cyclin D1 Attenuates Pancreatic Cancer Growth (2009) (17)
Response to Comment on: Morden et al. Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A Retrospective Cohort Study of Older Medicare Patients. Diabetes Care 2011;34:1965–1971 (2012) (17)
Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease. (1999) (17)
Cdk 4 / 6 Inhibition Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells (2012) (16)
Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment. (2018) (16)
Chronic pancreatitis: pathogenesis and molecular aspects. (2000) (16)
Human Fibroblast Growth Factor Receptor 1-IIIb Is a Functional Fibroblast Growth Factor Receptor Expressed in the Pancreas and Involved in Proliferation and Movement of Pancreatic Ductal Cells (2007) (15)
The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings. (1998) (15)
Identification and Characterization of Muscarinic Receptors in Cultured Human Pancreatic Carcinoma Cells (1989) (15)
Increased mdm2 expression and immunoreactivity in human pancreatic ductal adenocarcinoma. (1994) (14)
Searching for the Holy Grail: the cause of diabetes (1995) (14)
Nicardipine as antihypertensive monotherapy: positive effects on quality of life. (1991) (14)
A phase I dose escalation and pharmacokinetic (PK) study of intravenous (iv) aflibercept (VEGF Trap) plus weekly gemcitabine (Gem) in patients (pts) with advanced solid tumors: preliminary results (2008) (14)
Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice (2017) (14)
TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor. (1999) (14)
Altered expression of transforming growth factor-beta S in chronic renal rejection. (1996) (14)
Modulation of cytosolic free calcium levels by extracellular phosphate and lanthanum. (1987) (13)
Update on Diabetes Mellitus (2004) (13)
Quin 2 and Manganese Define Multiple Alterations in Cellular Calcium Homeostasis in Diabetic Rat Pancreas (1988) (13)
Heparin-binding EGF-like growth factor expression and biological action in human pancreatic cancer cells. (1996) (12)
Effect of lanthanum on pancreatic protein synthesis in streptozotocin-diabetic rats. (1983) (12)
Expression of transforming growth factor-β1,2, and 3 mRNA and protein in human cancers (1994) (12)
Residual inhibition of epidermal growth factor binding by pancreatic secretagogues and phorbol ester in rat pancreas (1985) (12)
Direct modulation of epidermal growth factor binding by cholecystokinin. (1983) (12)
Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1. (1996) (12)
FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer (2020) (11)
A Novel Type I Fibroblast Growth Factor Receptor Activates Mitogenic Signaling in the Absence of Detectable Tyrosine Phosphorylation of FRS2* (2000) (11)
Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagus (1990) (10)
Aberrant Expressions of AP-2&agr; Splice Variants in Pancreatic Cancer (2011) (10)
Manganese action on protein synthesis in diabetic rat pancreas: evidence for a possible physiological role. (1984) (10)
Circulating Thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm. (2019) (10)
[Molecular biology of pancreatic cancer: overexpression of fibroblast growth factors]. (1994) (10)
Effects of Malnutrition and Chronic Reserpine Treatment on Pancreatic Exocrine Function1 (1986) (10)
Effects of manganese deficiency and dietary composition on rat pancreatic enzyme content. (1987) (10)
Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells. (1999) (10)
Inhibition of epidermal growth factor binding in rat pancreatic acini by palmitoyl carnitine: evidence for Ca2+ and protein kinase C independent regulation. (1987) (10)
Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors. (1993) (10)
Circulating Leptin and Branched Chain Amino Acids—Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade (2018) (9)
Alterations in EGF binding to acini during pancreatic regeneration in the rat (1988) (9)
The application of differential display as a gene profiling tool. (2007) (9)
p38 MAPK in Pancreatic Cancer: Finding a Protective Needle in the Haystack (2014) (9)
Differential regulation of polysome mRNA levels in mouse Hepa-1C1C7 cells exposed to dioxin. (2011) (9)
Cytotoxic Effects of TGF‐α‐Pseudomonas Exotoxin A Fusion Protein in Human Pancreatic Carcinoma Cells (1996) (9)
Beyond Kras: MYC Rules in Pancreatic Cancer (2018) (8)
Synthesis and biological evaluation of Nα-hydroxysulfonyl-[Nle28,31]-CCK26–33 (1986) (8)
Potential role of the epidermal growth factor receptor in human pancreatic cancer (1990) (8)
Alteration of Cholecystokinin-Mediated Phosphatidylinositol Hydrolysis in Pancreatic Acini From Insulin-Deficient Rats: Evidence for Defective G Protein Activation (1991) (8)
Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma (2017) (8)
Discovery of a Novel Molecule that Regulates Tumor Growth and Metastasis (2008) (7)
MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection (2016) (7)
Improving the diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration using microRNAs. (2014) (7)
Overexpression of the Epidermal Growth Factor Receptor Family in Gastric Cancer Suggests a Role in Tumor Pathogenesis (1997) (7)
Manganese attenuates secretagogue-mediated phospholipid hydrolysis in AR42J cells. (1989) (7)
Manganese-stimulated phosphorylation of a rat pancreatic protein: identity with elongation factor 2. (1991) (7)
Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice (2015) (7)
Effects of 1-oleoyl-2-acetyl glycerol are distinct from those of phorbol ester in rat pancreatic acini. (1987) (6)
Effects of epidermal growth factor on growth response, morphology, and invasive potential of human endometrial carcinoma cell line RL95-2. (1991) (6)
Manganese as a modulator of signal transduction pathways. (1993) (6)
Role of Polypeptide Growth Factors and Their Receptors in Human Pancreatic Cancer (1998) (6)
Conventional Treatment of Pancreatic Cancer (1993) (6)
Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue. (2009) (6)
Isolated pancreatic acini from suckling and weanling rats: changes in amino acid incorporation and carbachol-stimulated amylase secretion with age. (1986) (5)
TGF-β 1 MEDIATED GROWTH INHIBITION IN COLO-357 CELLS THROUGH FUNCTIONAL INACTIVATION OF THE RETINOBLASTOMA PROTEIN (2005) (5)
Regulation of Pancreatic Exocrine Function by Manganese (1988) (5)
Cholecystokinin-induced phosphatidylinositol hydrolysis in rat pancreatic acinar cells: modulation by extracellular calcium and manganese. (1991) (5)
Activated Kras and INK 4 a / Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NFk B Signaling Pathways (2011) (5)
Pathogenesis of Pancreatic Cancer-Related Diabetes Mellitus: Quo Vadis? (2019) (5)
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. (2012) (5)
The joy of discovery (2006) (5)
Single‐Strand Conformation Polymorphism Analysis of the Epidermal Growth Factor Receptor at Codon 497 (1996) (4)
Long-term effect of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells (1990) (4)
Sugar-Coated Proteins Pave the Way to Improving Pancreatic Cancer Diagnosis (2016) (4)
Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium. (2022) (4)
PMTDS: a computational method based on genetic interaction networks for Precision Medicine Target-Drug Selection in cancer (2017) (4)
Proteomics of Disease (2005) (4)
A retrospective cohort study of older Medicare patients (2011) (4)
SMAD4‐dependent polysome RNA recruitment in human pancreatic cancer cells (2012) (4)
Growth factors and growth factor receptors in benign pancreatic disorders (1994) (4)
GASTROINTESTINAL , HEPATOBILIARY , AND PANCREATIC PATHOLOGY Nestin Delineates Pancreatic Cancer Stem Cells in Metastatic Foci of NOD / Shi-scid IL 2 R g null ( NOG ) Mice (2014) (3)
RelA: a tale of a stitch in time. (2016) (3)
Inhibition of Cyclin D 1 Expression in Human Pancreatic Cancer Cells Is Associated with Increased Chemosensitivity and Decreased Expression of Multiple Chemoresistance Genes 1 (1999) (3)
Differential distribution of human epidermal growth factor receptor family in acute pancreatitis (1995) (3)
Squeezing data from pancreatic juice (2006) (3)
Growth Factors in Human Pancreatic Cancer: Update on the Role of the Epidermal Growth Factor Receptor (1994) (3)
Manganese Modulates Protein Phosphorylation in the Rat Pancreas: In Vitro Evidence for Cation Selective Regulation (1990) (3)
Small Molecule Therapeutics Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS 1 Kinase Inhibitor NMSP 715 (2014) (3)
Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine. (1996) (3)
Shining the spotlight on shed kras in pancreatic cancer (2008) (3)
Pancreatic Cancer: Growth Factors and Growth Factor Receptors (1999) (3)
17 Smad4/TGF-b Signaling Pathways in Pancreatic Cancer Pathogenesis (2010) (2)
Entry of insulin into target cells: EM autoradiographic studies in vitro and in vivo (1978) (2)
Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis (2018) (2)
Methods for MicroRNA Profiling in Cancer (2017) (2)
Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells. (2001) (2)
Aberrant Transforming Growth Factor-β Signaling in Human Pancreatic Cancer: Translational Implications (2008) (2)
Targeted therapeutics in pancreatic cancer: a ray of hope. (2005) (2)
Protein Kinase C and Melanocyte Transformation (1988) (2)
Evidence that calcium is a hormonal second messenger (1978) (2)
Induction and expression of b igh 3 in pancreatic cancer cells (2002) (2)
Epidermal Growth Factor Receptor: Its Role in Pancreatic Cancer1 (1986) (2)
Abstract C31: The glycosaminoglycan syndecan-4 facilitates pancreatic cancer progression and biologic aggressiveness (2019) (1)
Primary adrenocortical tumors: EGFR, c-Kit and Her-2/neu receptor staining patterns (2005) (1)
Cytotoxic effects of tumor necrosis factor and gamma interferon on cultured human pancreatic carcinoma cells (1987) (1)
Effects of epidermal growth factor on pancreatic acinar cells in serum-free culture (1984) (1)
Growth factors, receptors, and regulation normal and malignant (1994) (1)
Angiogenesis signaling pathways as targets in cancer therapy (2010) (1)
Abstract 2951: DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine. (2013) (1)
Abstract 177: MiR-10b promotes migration and invasion in pancreatic cancer cells (2012) (1)
Investigational strategies for detection and intervention in early-stage pancreatic cancer (1994) (1)
Microenvironment and Immunology Reprogramming Tumor-Associated Dendritic Cells In Vivo UsingmiRNAMimetics Triggers Protective Immunity against Ovarian Cancer (2012) (1)
Abstract 3400: An angiogenesis gene signature points to active TGF-beta/JAK signaling pathways in a subset of human pancreatic ductal adenocarcinoma cancer patients that are distinct from pathways in pancreatic neuroendocrine tumors (2016) (1)
Abstract 969: TGF-beta cross-talks with the EGF receptor family to promote proliferation of pancreatic cancer cells with dysfunctional RB (2014) (1)
Adenovirus mediated transfer of a truncated fibroblast growth factor (FGF) typ I receptor blocks FGF2 signaling in pancreatic cancer cells (2003) (1)
Abstract LB-360: Fluorescence-based co-registration with protein markers reveals distinct cellular compartments for altered microRNA expression in solid tumors (2010) (0)
Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance (2018) (0)
Panc-I human pancreatic carcinoma cells have an abundance of epidermal growth factor receptors and a translocation on the short arm of chromosome 7 (1985) (0)
Aberrant Signaling Pathways in Pancreatic Cancer (2010) (0)
Abstract 4862: Protein arginine methyltransferase 5 as a tumor promoter and therapeutic target in gastrointestinal cancers (2018) (0)
Effects of manganese deficiency on the exocrine pancreas (1985) (0)
Receptors | Fibroblast Growth Factor Receptors and Cancer-Associated Perturbations (2013) (0)
Abstract 2917: Differentiation therapy and the mechanisms that terminate malignant proliferation (2018) (0)
Targeting the Tumor Microenvironment (2015) (0)
OVEREXPRESSION OF 14-3-3?? CONFERS A GROWTH AND SURVIVAL ADVANTAGE IN PANCREATIC CANCER (2006) (0)
The Epidermal Growth Factor Receptor-Transforming Growth Factor Alpha Autocrine Cycle (2020) (0)
Abstract 3055: PD-0332991, a selective cyclin-dependent-kinase 4/6 Inhibitor, upregulates multiple genes promoting invasion and metastasis in pancreatic ductal adenocarcinoma (2012) (0)
Enhanced expression of apoptotic factors implicate a role in human pancreatic cancer (1995) (0)
Abstract B115: PD0332991 induces epithelial to mesenchymal transition in pancreatic cancer (2015) (0)
Mo1195 miRNA Can Identify Intraductal Papillary Mucinous Neoplasms (IPMNs) With Advanced Dysplasia (2012) (0)
EXPRESSION OF FGFR1-IIIB INHIBITS PANCREATIC CANCER CELL GROWTH IN VITRO AND IN VIVO (2006) (0)
Abstract 2457: Nestin regulates pancreatic cancer stem cell functions (2011) (0)
In vitro regulation of pancreatic acinar cell function by insulin (1978) (0)
Antagonistic effects of cholecystokinin on pancreatic protein synthesis: Role of calcium influx (1982) (0)
Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Enhanced Expression of Fibroblast Growth Factor Receptor 2 IIIc Promotes Human Pancreatic Cancer Cell Proliferation (2012) (0)
Part VI Disease Pathophysiology: Translational Implications (2010) (0)
Abstract 4180: TGF-beta promotes angiogenesis in an RB-deficient, Kras-driven mouse model of pancreatic cancer (2015) (0)
Overexpression of TGF-?1 and TGF-? receptor type II but not of TGF-?2 and TGF-? receptor type III in human liver cirrhosis (1995) (0)
Abstract 3076: p53 homologue p63 trans-activates epidermal growth factor (EGF) receptor and 14-3-3α and thus promotes tumorigenesis and chemoresistance in pancreatic cancer (2012) (0)
Glypican-3 is a potential tumor marker for hepatocellular carcinoma (2000) (0)
Blocked by a Truncated Epidermal Growth Factor Receptor Multiple Mitogenic Pathways in Pancreatic Cancer Cells Are Updated (2002) (0)
Alteration of fibroblast growth factor expression following acute pancreatitis (1998) (0)
Transforming growth factor (8 mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium (cell-cell interactions/stromelysin/matrilysin) (2005) (0)
Modeling Pancreatic Cancer Tumor Microenvironment using a Microfluidics Culture System (2016) (0)
INTERLEUKIN-13 EXERTS AUTOCRINE GROWTH PROMOTING EFFECTS IN HUMAN PANCREATIC CANCER AND ITS EXPRESSION CORRELATES WITH A PROPENSITY FOR LYMPH NODE METASTASES (2007) (0)
Abstract 4961: Longitudinal bioluminescence imaging of primary versus abdominal metastatic tumor growth in orthotopic pancreatic tumor models in NOD/SCIDγ(-/-) mice (2014) (0)
Abstract 249: Inhibition of nestin using siRNA as a novel therapeutic option for pancreatic cancer. (2013) (0)
Activated K‐Ras and INK4a/Arf Deficiency Promote Aggressiveness of Pancreatic Cancer by Induction of EMT Consistent With Cancer Stem Cell Phenotype (2014) (0)
Epidermal growth factor receptor but not C-ERBB-3 is overexpressed in oesophageal carcinomas (1995) (0)
The human IIIb-mRNA splice variant of FGFR1 is a functional transmembrane tyrosine kinase receptor and inhibits pancreatic cancer cell growth (2005) (0)
Alteration of Type III Receptor Expression Receptor in Human Pancreatic Cancer Cells without β Factor Enhanced Expression of the Type II Transforming Growth (2006) (0)
Transcriptional up-regulation of transforming growth factor-β (TGF-β) receptors by TGF-β1 correlates with expression of cyclin d-dependent kinase inhibitors (1998) (0)
Abstract 4101: Fibroblast growth factor receptor (FGFR) 2 IIIc, is a novel molecular target for suppressing pancreatic cancer cell growth and migration (2010) (0)
An inhibitor of the mitotic kinase, MPS1, is selective towards pancreatic cancer cells (2014) (0)
Abstract 4079: Perturbations in tat-interacting protein 30 (TIP30) levels contribute to pancreatic cancer aggressiveness (2018) (0)
Contents, Vol. 49, 1986 (1986) (0)
TGF-βs and their receptors influence the outcome in Crohn's disease (1998) (0)
Chronic pancreatitis isassociated withincreased concentrations ofepidermal growth factor receptor, transforming growth factor oa, and phospholipase Cry (1994) (0)
RB loss in conjunction with oncogenic Kras causes perturbations in TGF-β signaling and upregulates AGR2 expression (2013) (0)
Disturbance in apoptosis influences the outcome of patients with pancreatic cancer (1998) (0)
Chronic pancreatitis (1994) (0)
Autocrine Regulation in Human Pancreatic Cancer (2020) (0)
Overexpression of platelet-derived growth factor (PDGF) receptors in human pancreatic ductal adenocarcinoma (1995) (0)
Nerve G rowth F actor E xpression C orrelates W ith P erineural Invasion a nd P ain i n H uman P ancreatic C ancer (1999) (0)
Structure-function relationships of new synthetic CCK/sub 8/ analogs in rat brain and pancreas (1986) (0)
Heparin Prowess: Favorable Vascular-Immune Reprogramming in Pancreatic Cancer. (2023) (0)
Therapeutic Discovery Cdk 4 / 6 Inhibition InducesEpithelial – MesenchymalTransition and Enhances Invasiveness in Pancreatic Cancer Cells (2012) (0)
Overexpression of transforming growth factor βs and their receptors in acute pancreatitis in humans (1995) (0)
MicroRNA expression in common hepatic artery lymph nodes as a prognostic marker in pancreatic ductal adenocarcinoma (2015) (0)
OVER-EXPRESSION OF FGFR2 IIIC ISOFORM ENHANCES THE GROWTH OF PANCREATIC CANCER (2008) (0)
Hormonal Regulation of Cell Proliferation and Differentiation : Cellular Mechanisms (2017) (0)
Loss o f B eta-Catenin E xpression i n M etastatic G astric C ancer (2003) (0)
CHAPTER 336 – Development and Regulatory Signaling in the Pancreas (2003) (0)
Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33. (1986) (0)
Erratum: Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1 (Cancer Research (2007) 67, (10309-10316)) (2007) (0)
NEUROPILIN-1 ASSOCIATION WITH c-MET IN PANCREATIC CANCER CELLS ENHANCES HEPATOCYTE GROWTH FACTOR-MEDIATED CELL INVASION (2007) (0)
Reduction of the angiostatic chemokine SF-1 and concomitant increase of its receptor CXCR-4 in colorectal cancer (2000) (0)
Increased sensitivity to gemcitabine following Bcl-xL antisense treatment in pancreatic cancer cells (2000) (0)
Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways (2011) (0)
3 – Multifunctional Role of the Epidermal Growth Factor Receptor in the Regulation of Cell Growth (1990) (0)
Pancreatic Cancer: Translational Implications (2009) (0)
Insulin-like Growth Factor I Overexpression in Human Pancreatic Cancer : Evidence for Autocrine and Paracrine Roles 1 (1995) (0)
Novel type I fibroblast growth factor receptor in pancreatic cancer (2000) (0)
3513 POSTER Interleukin-13 exerts autocrine growth promoting effects in human pancreatic cancer and its expression correlates with a propensity for lymph node metastases (2007) (0)
KaI1 influences the metastatic potential in hepatocellular carcinomas (1998) (0)
Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells (2018) (0)
The IIIc splice variant of FGF receptor-1 contributesto the transformation of pancreatic ductal cells in vitro and in vivo (2000) (0)
Altered expression of the human epidermal growth factor (HER) family in acute pancreatitis suggests a prominent role for HER-1 (1995) (0)
Abstract 4433: RB mediates TGF-β effects on growth inhibition and invasion in pancreatic cancer cells (2012) (0)
Abstract 5698: MicroRNA-31 acts as an oncomir in lung cancer by repressing specific tumor suppressors (2010) (0)
Abstract B19: Redox factor 1 (Ref-1) signaling in the interaction between pancreatic tumor cells and cancer-associated fibroblasts (2015) (0)
Glypican-1 is crucial for the angiogenic and metastatic potential of pancreatic cancer cells (2008) (0)
Manganese as a Potential Modulator of Second Messenger Pathways (1990) (0)
Abstract 2811: GPC1 promotes tumor growth and angiogenesis in a KrasG12D- Driven mouse model of pancreatic cancer (2011) (0)
Abstract 5240: Establishment of novel human pancreatic cancer cell lines from liver and lung metastases in NOD/SCID/γcnull(NOG) mice (2011) (0)
rescence-Based Codetection with Protein Markers eals Distinct Cellular Compartments for Altered (2010) (0)
Abstract 1204: Fibroblast growth factor receptor 2 as a novel therapeutic target for cancer cell growth and angiogenesis in human pancreatic cancer (2011) (0)
Abstract 223: ΔNp63α, a p53 family member protein, promotes tumor progression in pancreatic cancer (2011) (0)
Regulatory Signaling in Pancreatic Organogenesis (2010) (0)
Abstract A135: Uncovering tumor suppressive and oncogenic microRNAs in lung cancer (2008) (0)
VEGF remains an interesting target in advanced pancreas cancer ( APCA ) : results of a multi-institutional phase II study of bevacizumab , gemcitabine , and infusional 5-fl uorouracil in patients with APCA (2012) (0)
Epidermal growth factor receptor expression inpancreatic lesions induced intheratbyazaserine (1996) (0)
Neuropilin-1 associates with c-Met and modulates hepatocyte growth factor actions (2007) (0)
Response to Le Large et al. (2015) (0)
“Pancreatic Cancer Signature Center: Providing the Research Tools Necessary to Advance Pancreatic Cancer Patient Care” (2010) (0)
Abstract 408: Stem cell marker Nestin regulated the migration and invasion of pancreatic cancer cells (2010) (0)
Abstract 2449: FGFR4 inhibitor BLU9931 induces cellular senescence in pancreatic ductal adenocarcinoma cell lines promoting sensitivity to senolytic therapy (2021) (0)
C-ERBB-2 and C-ERBB-3, but not egfreceptor are overexpressed in (advanced) colorectal cancer (1996) (0)
12 Correlation of chromosome 7 alterations with expression of epidermal growth factor receptor (EGF) in human glial and pancreatic carcinomas (1987) (0)
Subject Index Vol. 11, 1994 (1994) (0)
Kinases, phosphatases, oncogenes, and tumor-suppressor genes (1994) (0)
Divergent effects of growth factors on anchorage independent proliferation of panc 1 human pancreatic carcinoma cells (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Murray Korc?

Murray Korc is affiliated with the following schools:

Murray Korc's Academic­Influence.com Rankings

Murray Korc's Degrees

Why Is Murray Korc Influential?

Murray Korc's Published Works

Published Works

What Schools Are Affiliated With Murray Korc?

Murray Korc's AcademicInfluence.com Rankings